Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
In Reply: Drs Budenholzer and Welch assert that discussions about the cost-effectiveness of colorectal cancer screening may be premature in light of the insufficient evidence about the effectiveness of colonoscopy. We agree that the ideal evidence would be from randomized clinical trials. However, a screening trial of the general population would require a fairly large sample size and long time horizon. Even with a large anticipated risk reduction, the baseline incidence of colorectal cancer is relatively small.
Frazier AL, Kuntz KM. Cost-effectiveness of Colorectal Cancer Screening—Reply. JAMA. 2001;285(4):407–408. doi:10.1001/jama.285.4.407
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: